Four HudsonAlpha researchers are attending an Undiagnosed Disease Network (UDN) steering committee meeting today and tomorrow in 
Washington, D.C. Howard Jacob, PhD, executive vice president for medical genomics; faculty investigators Liz Worthey, PhD, and Joe Lazar, PhD; and CSL lab director Molly Schroeder, PhD, are meeting with other scientists from UDN to discuss recent discoveries and determine best practices for using genomics to diagnose disease.
The Undiagnosed Diseases Network (UDN) is a research study that is funded by the National Institutes of Health Common Fund. Its purpose is to bring together clinical and research experts from across the United States to solve the most challenging medical mysteries using advanced technologies.
The study aims to both help individual patients and families and contribute to the understanding of how the human body works.
HudsonAlpha is one of two sequencing cores for the UDN. The project at HudsonAlpha is led by Howard Jacob and Liz Worthey.
